Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion

Journal of Cell Science

Volumn 123, Issue 18, 2010, Pages 3094-3101

  Suzuki, Yasuhiro ^a   Kobayashi, Miho ^a   Miyashita, Hiroki ^a   Ohta, Hideki ^b   Sonoda, Hikaru ^b   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Angiogenesis; Endothelial cell; Molecular chaperon; Secretion; Ubiquitylation; Vasohibin

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; SMALL VASOHIBIN BINDING PROTEIN; UNCLASSIFIED DRUG; VASOHIBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; EPITHELIUM CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DOGS; ENDOTHELIAL CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN TRANSPORT;

MUS;

EID: 77956928325     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.067538     Document Type: Article

References (47)

1. Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S. et al. (1997). Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. USA 94, 861-866.
2. Calderwood, S. K., Mambula, S. S. and Gray, P. J., Jr (2007). Extracellular heat shock proteins in cell signaling and immunity. Ann. NY Acad. Sci. 1113, 28-39.
3. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
4. Colland, F., Jacq, X., Trouplin, V., Mougin, C., Groizeleau, C., Hamburger, A., Meil, A., Wojcik, J., Legrain, P. and Gauthier, J. M. (2004). Functional proteomics mapping of a human signaling pathway. Genome Res. 14, 1324-1332.
5. Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P. and Xu, H. (2003). Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. USA 100, 721-726.
6. Gaspar, C., Cardoso, J., Franken, P., Molenaar, L., Morreau, H., Moslein, G., Sampson, J., Boer, J. M., de Menezes, R. X. and Fodde, R. (2008). Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am. J. Pathol. 172, 1363-1380.
7. Hegde, R. S. and Kang, S. W. (2008). The concept of translocational regulation. J. Cell Biol. 182, 225-232.
8. Heishi, T., Hosaka, T., Suzuki, Y., Miyashita, H., Oike, Y., Takahashi, T., Nakamura, T., Arioka, S., Mitsuda, Y., Takakura, T. et al. (2010). Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am. J. Pathol. 176, 1950-1958.
9. Hellstrom, M., Phng, L. K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A. K., Karlsson, L., Gaiano, N. et al. (2007). Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780.
10. Hishiya, A. and Takayama, S. (2008). Molecular chaperones as regulators of cell death. Oncogene 27, 6489-6506.
11. Horvath, I., Multhoff, G., Sonnleitner, A. and Vigh, L. (2008). Membrane-associated stress proteins: more than simply chaperones. Biochim. Biophys. Acta 1778, 1653-1664.
12. Hosaka, T., Kimura, H., Heishi, T., Suzuki, Y., Miyashita, H., Ohta, H., Sonoda, H., Moriya, T., Suzuki, S., Kondo, T. et al. (2009). Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. Am. J. Pathol. 175, 430-439.
13. Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1473, 172-185.
14. Jiang, J., Cyr, D., Babbitt, R. W., Sessa, W. C. and Patterson, C. (2003). Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. J. Biol. Chem. 278, 49332-49341.
15. Keller, M., Ruegg, A., Werner, S. and Beer, H. D. (2008). Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831.
16. Kerbel, R. S. (2008). Tumor angiogenesis. N. Engl. J. Med. 358, 2039-2049.
17. Kimura, H., Miyashita, H., Suzuki, Y., Kobayashi, M., Watanabe, K., Sonoda, H., Ohta, H., Fujiwara, T., Shimosegawa, T. and Sato, Y. (2009). Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 113, 4810-4818.
18. Kobayashi, M., Nishita, M., Mishima, T., Ohashi, K. and Mizuno, K. (2006). MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J. 25, 713-726. (Pubitemid 43292434)
19. Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L. and Lewis, J. (2007). Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134, 839-844.
20. Martin-Belmonte, F., Arvan, P. and Alonso, M. A. (2001). MAL mediates apical transport of secretory proteins in polarized epithelial Madin-Darby canine kidney cells. J. Biol. Chem. 276, 49337-49342.
21. Muchowski, P. J., Schaffar, G., Sittler, A., Wanker, E. E., Hayer-Hartl, M. K. and Hartl, F. U. (2000). Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. USA 97, 7841-7846.
22. Nasu, T., Maeshima, Y., Kinomura, M., Hirokoshi-Kawahara, K., Tanabe, K., Sugiyama, H., Sonoda, H., Sato, Y. and Makino, H. (2009). Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes 58, 2365-2375.
23. Nickel, W. (2005). Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614. (Pubitemid 40959689)
24. Nickel, W. (2007). Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2. J. Cell Sci. 120, 2295-2299.
25. Nickel, W. and Rabouille, C. (2009). Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148-155.
26. Ohta, H., Tsuji, T., Asai, S., Sasakura, K., Teraoka, H., Kitamura, K. and Kangawa, K. (1999). One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin. Chem. 45, 244-251.
27. Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G. et al. (2004). CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703-714.
28. Piotrowicz, R. S., Martin, J. L., Dillman, W. H. and Levin, E. G. (1997). The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J. Biol. Chem. 272, 7042-7047.
29. Sabath, E., Negoro, H., Beaudry, S., Paniagua, M., Angelow, S., Shah, J., Grammatikakis, N., Yu, A. S. and Denker, B. M. (2008). Galpha12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J. Cell Sci. 121, 814-824.
30. Sato, H., Abe, T., Wakusawa, R., Asai, N., Kunikata, H., Ohta, H., Sonoda, H., Sato, Y. and Nishida, K. (2009). Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetologia 52, 359-361.
31. Sato, Y. (2006). Update on endogenous inhibitors of angiogenesis. Endothelium 13, 147-155.
32. Sato, Y. and Sonoda, H. (2007). The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, 37-41.
33. Seelenmeyer, C., Wegehingel, S., Lechner, J. and Nickel, W. (2003). The cancer antigen CA125 represents a novel counter receptor for galectin-1. J. Cell Sci. 116, 1305-1318.
34. Shen, J., Yang, X., Xiao, W. H., Hackett, S. F., Sato, Y. and Campochiaro, P. A. (2006). Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J. 20, 723-725.
35. Shibuya, T., Watanabe, K., Yamashita, H., Shimizu, K., Miyashita, H., Abe, M., Moriya, T., Ohta, H., Sonoda, H., Shimosegawa, T. et al. (2006). Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler. Thromb. Vasc. Biol. 26, 1051-1057.
36. Shimizu, K., Watanabe, K., Yamashita, H., Abe, M., Yoshimatsu, H., Ohta, H., Sonoda, H. and Sato, Y. (2005). Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem. Biophys. Res. Commun. 327, 700-706.
37. Siekmann, A. F. and Lawson, N. D. (2007). Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445, 781-784.
38. Sonoda, H., Ohta, H., Watanabe, K., Yamashita, H., Kimura, H. and Sato, Y. (2006). Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin. Biochem. Biophys. Res. Commun. 342, 640-646.
39. Takahashi, T., Tada, M., Igarashi, S., Koyama, A., Date, H., Yokoseki, A., Shiga, A., Yoshida, Y., Tsuji, S., Nishizawa, M. et al. (2007). Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3′-phosphate and 3′-phosphoglycolate ends. Nucleic Acids Res. 35, 3797-3809.
40. Tamaki, K., Moriya, T., Sato, Y., Ishida, T., Maruo, Y., Yoshinaga, K., Ohuchi, N. and Sasano, H. (2009). Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci. 100, 88-94.
41. Torrado, L. C., Temmerman, K., Muller, H. M., Mayer, M. P., Seelenmeyer, C., Backhaus, R. and Nickel, W. (2009). An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation. J. Cell Sci. 122, 3322-3329.
42. Wakusawa, R., Abe, T., Sato, H., Yoshida, M., Kunikata, H., Sato, Y. and Nishida, K. (2008). Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes. Am. J. Ophthalmol. 146, 235-243.
43. Watanabe, K., Hasegawa, Y., Yamashita, H., Shimizu, K., Ding, Y., Abe, M., Ohta, H., Imagawa, K., Hojo, K., Maki, H. et al. (2004). Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J. Clin. Invest. 114, 898-907.
44. Wickner, S., Maurizi, M. R. and Gottesman, S. (1999). Posttranslational quality control: folding, refolding, and degrading proteins. Science 286, 1888-1893. (Pubitemid 129515889)
45. Yamashita, H., Abe, M., Watanabe, K., Shimizu, K., Moriya, T., Sato, A., Satomi, S., Ohta, H., Sonoda, H. and Sato, Y. (2006). Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Biochem. Biophys. Res. Commun. 345, 919-925.
46. Yamazaki, T., Yoshimatsu, Y., Morishita, Y., Miyazono, K. and Watabe, T. (2009). COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 14, 425-434.
47. Yoshinaga, K., Ito, K., Moriya, T., Nagase, S., Takano, T., Niikura, H., Yaegashi, N. and Sato, Y. (2008). Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci. 99, 914-919.